loading
前日終値:
$175.74
開ける:
$175.56
24時間の取引高:
1.01M
Relative Volume:
1.10
時価総額:
$10.75B
収益:
$4.09B
当期純損益:
$-404.84M
株価収益率:
-26.22
EPS:
-6.7469
ネットキャッシュフロー:
$1.24B
1週間 パフォーマンス:
+25.42%
1か月 パフォーマンス:
+28.68%
6か月 パフォーマンス:
+63.42%
1年 パフォーマンス:
+41.43%
1日の値動き範囲:
Value
$173.73
$177.80
1週間の範囲:
Value
$162.60
$182.99
52週間の値動き範囲:
Value
$95.49
$182.99

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1129)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,800
Name
Twitter
@jazzpharma
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

JAZZ を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
176.93 10.68B 4.09B -404.84M 1.24B -6.7469
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-15 開始されました Deutsche Bank Buy
2025-03-07 アップグレード UBS Neutral → Buy
2025-02-26 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-02-13 アップグレード Wells Fargo Equal Weight → Overweight
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
Nov 22, 2025

A Look at Jazz Pharmaceuticals's Valuation After Landmark HERIZON-GEA-01 Ziihera Trial Results - simplywall.st

Nov 22, 2025
pulisher
Nov 21, 2025

Why Jazz Pharmaceuticals plc (J7Z) stock remains stableEarnings Performance Report & Verified Short-Term Plans - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

What MACD trends signal for Jazz Pharmaceuticals plc (J7Z) stock2025 Winners & Losers & Capital Efficiency Focused Ideas - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How strong is Jazz Pharmaceuticals plc stock balance sheetJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Jazz Pharmaceuticals Insider Sold Shares Worth $3,259,538, According to a Recent SEC Filing - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

Cozadd Bruce C, director at Jazz Pharmaceuticals, sells $3.2 million in stock By Investing.com - Investing.com South Africa

Nov 21, 2025
pulisher
Nov 21, 2025

Insider Sell: Rick Winningham Sells 5,500 Shares of Jazz Pharmac - GuruFocus

Nov 21, 2025
pulisher
Nov 20, 2025

Cozadd Bruce C, director at Jazz Pharmaceuticals, sells $3.2 million in stock - Investing.com India

Nov 20, 2025
pulisher
Nov 20, 2025

Iannone, Jazz Pharmaceuticals EVP, sells $1.2m in JAZZ stock By Investing.com - Investing.com South Africa

Nov 20, 2025
pulisher
Nov 20, 2025

Why Jazz Pharmaceuticals plc (J7Z) stock appeals to dividend investorsChart Signals & Entry Point Confirmation Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Jazz Pharmaceuticals plc (J7Z) stock undervalued at current priceQuarterly Growth Report & Stock Timing and Entry Methods - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Jazz Pharmaceuticals Insider Sold Shares Worth $1,204,573, According to a Recent SEC Filing - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Will Jazz Pharmaceuticals plc (J7Z) stock rise with strong economy2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

What technical charts say about Jazz Pharmaceuticals plc stockWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

No-Moat Jazz's Growth Supported by Positive Phase 3 Data for Ziihera and Strong Uptake of Xywav - Morningstar

Nov 20, 2025
pulisher
Nov 19, 2025

Insider Sell: Robert Iannone Sells Shares of Jazz Pharmaceuticals PLC - GuruFocus

Nov 19, 2025
pulisher
Nov 19, 2025

Iannone, Jazz Pharmaceuticals EVP, sells $1.2m in JAZZ stock - Investing.com India

Nov 19, 2025
pulisher
Nov 19, 2025

Will Jazz Pharmaceuticals plc (J7Z) stock outperform benchmarksRisk Management & Weekly Chart Analysis and Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Technical analysis overview for Jazz Pharmaceuticals plc stockTrade Risk Assessment & Growth Focused Entry Point Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Visual analytics tools that track Jazz Pharmaceuticals plc performanceMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Truist Adjusts Price Target on Jazz Pharmaceuticals Public to $220 From $205, Maintains Buy Rating - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

Jazz Pharmaceuticals (JAZZ) Is Up 32.0% After Positive Phase 3 Results for Ziihera in HER2-Positive Cancer - simplywall.st

Nov 19, 2025
pulisher
Nov 19, 2025

Can Jazz Pharmaceuticals plc stock resist sector downturnsWeekly Trade Review & Expert Verified Stock Movement Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Why Jazz Pharmaceuticals plc (J7Z) stock could be next leaderJuly 2025 Action & Community Consensus Picks - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Is Jazz Pharmaceuticals’ Rally A Buying Signal? - StocksToTrade

Nov 18, 2025
pulisher
Nov 18, 2025

Single Trial Success Stories: UCB’s Kygevvi Joins US FDA Approvals With Confirmatory Evidence - Citeline News & Insights

Nov 18, 2025

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):